GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY. Issue 2 (22nd June 2018)

• Record Type: Journal Article
• Authors: Michaiel, George; Strother, Douglas; Gottardo, Nicholas; Bartels, Ute; Coltin, Hallie; Eisenstat, David D; Hukin, Juliette; Johnston, Donna L; Wilson, Beverly; Zelcer, Shayna; Hansford, Jordan R; Wells, Olivia; AbdelBaki, Mohamed S; Abu-Arja, Mohammad H; Cole, Kristina A; Dhall, Girish; Fisher, Paul G; Hoffman, Lindsey; Leary, Sarah E S; Pickle, Emily E Owens; Smiley, Natasha P; Smith, Amy; Vinitsky, Anna; Vitanza, Nicholas A; Wright, Avery; Yeo, Kee K; Chow, Lionel M L; Kirby, Maria; Valvi, Santosh; Vanan, Magimairajan I; Wong, Grace; Ziegler, David; Bouffet, Eric; Lafay-Cousin, Lucie;
• Is Part Of: Neuro-oncology. Volume 20:Issue 2(2018)supplement 2
• Page Start: i88
• Page End: i88
• Publication Date: 2018-06-22
• Subjects: Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noy059.270
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: BACKGROUND: IGTS is a rare phenomenon of paradoxical germ cell tumor (GCT) growth during or following treatment despite normalization of tumor markers. We sought to evaluate the frequency, clinical characteristics and outcome of IGTS in patients in 21 North-American and Australian institutions. METHODS: Patients with IGTS diagnosed from 2000-2017 were retrospectively evaluated. RESULTS: Out of 739 GCT diagnoses, IGTS was identified in 33 patients (4.5%). IGTS occurred in 9/191 (4.7%) mixed-malignant GCTs, 4/22 (18.2%) immature teratomas (ITs), 3/472 (0.6%) germinomas/germinomas with mature teratoma, and in 17 secreting non-biopsied tumours. Median age at GCT diagnosis was 10.9 years (range 1.8-19.4). Male gender (84%) and pineal location (88%) predominated. Of 27 patients with elevated markers, median serum AFP and ßHCG were 70 ng/mL (range 9.2-932) and 44 IU/L (range 4.2-493), respectively. IGTS occurred at a median time of 2 months (range 0.5-32) from diagnosis, during chemotherapy in 85%, radiation in 3%, and after treatment completion in 12%. Surgical resection was attempted in all, leading to gross total resection in 76%. Most patients (79%) resumed GCT chemotherapy/radiation after surgery. At a median follow-up of 5.3 years (range 0.3-12), all but 2 patients are alive (1 succumbed to progressive disease, 1 to malignant transformation of GCT). CONCLUSION: IGTS occurred in less than 5% of patients with GCT and most commonly after initiation of chemotherapy. IGTS was more common in patients with IT-only on biopsy than with mixed-malignant GCT. Surgical resection is a principal treatment modality. Survival outcomes for patients who developed IGTS are favourable.